Zobrazeno 1 - 10
of 60
pro vyhledávání: '"Bronchodilator Agent"'
Publikováno v:
BMC Pulmonary Medicine, Vol 24, Iss 1, Pp 1-11 (2024)
Abstract Background and objectives Few studies have reported which inhaled combination therapy, either bronchodilators and/or inhaled corticosteroids (ICSs), is beneficial in patients with bronchiectasis and airflow obstruction. Our study compared th
Externí odkaz:
https://doaj.org/article/ed961ae74dfb4f999b141db01c18adda
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Cazzola, Mario, Rogliani, Paola, Laitano, Rossella, Calzetta, Luigino, Matera, Maria Gabriella
Publikováno v:
International Journal of Chronic Obstructive Pulmonary Disease
Mario Cazzola,1 Paola Rogliani,1 Rossella Laitano,1 Luigino Calzetta,2 Maria Gabriella Matera3 1Unit of Respiratory Medicine, Department of Experimental Medicine, University of Rome Tor Vergata, Rome, Italy; 2Unit of Respiratory Diseases and Lung Fun
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::beb3fddf8a5c59fd837dc8389b56f60c
https://doi.org/10.2147/copd.s345263
https://doi.org/10.2147/copd.s345263
Autor:
Luigino Calzetta, Maria Gabriella Matera, Paola Rogliani, Beatrice Ludovica Ritondo, Alfredo Chetta
Publikováno v:
Expert Review of Respiratory Medicine. 16:357-365
Objectives: The recent publication of additional data retrieval for patients missing week 52 vital status in the original analyses of the ETHOS study provides the urgent need of updating previous network meta-analyses (NMA) to produce stronger eviden
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::aae2344cf1570e66b6b426d758d298a2
https://doi.org/10.1080/17476348.2021.1951237
https://doi.org/10.1080/17476348.2021.1951237
Autor:
Francesco NUCERA, Andrea BIANCO, Teresa DAVID, Ilaria SALVATO, Ian M. ADCOCK, Gaetano CARAMORI
Publikováno v:
Minerva Medica. 113
There is no justification for a therapeutic nihilism in clinical practice because current management (pharmacological and non-pharmacological) of the patients with chronic obstructive pulmonary disease (COPD) according to treatable traits is effectiv
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::54c28fbbb504fa0741444c046c25a748
https://doi.org/10.23736/s0026-4806.22.08001-6
https://doi.org/10.23736/s0026-4806.22.08001-6
Publikováno v:
Current Opinion in Pharmacology. 56:74-84
The management of chronic obstructive pulmonary disease (COPD) is fundamentally still heavily dependent on the use of bronchodilators and corticosteroids. Therefore, there is a need for alternative, more effective and safer therapeutic approaches. In
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cfe710579289b92cb18b586eb6702f61
https://doi.org/10.1016/j.coph.2020.11.003
https://doi.org/10.1016/j.coph.2020.11.003
Autor:
Grace Oscullo, Alberto García-Ortega, Mario Cazzola, Paola Rogliani, Maria Gabriella Matera, Miguel Ángel Martínez-García
Publikováno v:
Drugs
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
instname
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
instname
Currently, there is much controversy surrounding the therapeutic approach to pulmonary function abnormalities in patients with bronchiectasis and, consequently, whether and when to use bronchodilators in these patients. National and international gui
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e85290eed548c42c1811c5811d2af4a6
https://fundanet.iislafe.san.gva.es/publicaciones/ProdCientif/PublicacionFrw.aspx?id=15239
https://fundanet.iislafe.san.gva.es/publicaciones/ProdCientif/PublicacionFrw.aspx?id=15239
Autor:
Alessandro Sanduzzi, Maria Gabriella Matera, Pasquale Ambrosino, Mauro Maniscalco, Silvia Stufano, Salvatore Fuschillo, Mario Cazzola
Publikováno v:
Respiratory Medicine
Background The usefulness of bronchodilators in coronavirus diseases 2019 (COVID-19) survivors is still uncertain, especially for patients with a concomitant obstructive lung disease. We aimed at verifying the level of bronchodilator reversibility in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4a67fa47531cd21f4416bad4d0999c79
https://pubmed.ncbi.nlm.nih.gov/33873099
https://pubmed.ncbi.nlm.nih.gov/33873099
Autor:
Ivan Nikolaev, Paola Rogliani, Beatrice Ludovica Ritondo, Luigino Calzetta, Francesco Facciolo, Maria Gabriella Matera
LABA/ICS and LABA/LAMA/ICS combinations elicit beneficial effects in asthma. Specific evidence concerning the impact of combining indacaterol acetate (IND), glycopyrronium bromide (GLY), and mometasone furoate (MF) on human airway hyperresponsiveness
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::83268720e833f681c3156b58458e17d2
http://hdl.handle.net/2108/285920
http://hdl.handle.net/2108/285920
Autor:
Maria Gabriella Matera, Beatrice Ludovica Ritondo, Luigino Calzetta, Josuel Ora, Paola Rogliani
Introduction: The role of long-acting muscarinic antagonists (LAMAs) is well established in uncontrolled asthma, but not in milder stages. Areas covered: This review examines the main randomized controlled trials (RCTs) that have investigated LAMAs a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::71d1c7892306d19b4645e3ef22c34c55
http://hdl.handle.net/2108/285632
http://hdl.handle.net/2108/285632